CRVL
CRVL
NASDAQ · Health Care

Corvel Corp

$71.83
+1.16 (+1.64%)
Financial Highlights (FY 2026)
Revenue
957.51M
Net Income
110.23M
Gross Margin
24.3%
Profit Margin
11.5%
Rev Growth
+10.1%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 24.3% 24.3% 67.6% 67.6%
Operating Margin 14.9% 13.4% 15.2% 17.6%
Profit Margin 11.5% 10.9% 13.8% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 957.51M 869.83M 770.01M 945.74M
Gross Profit 232.58M 211.28M 520.79M 639.64M
Operating Income 142.96M 116.88M 116.96M 166.22M
Net Income 110.23M 90.12M 106.52M 124.56M
Gross Margin 24.3% 24.3% 67.6% 67.6%
Operating Margin 14.9% 13.4% 15.2% 17.6%
Profit Margin 11.5% 10.9% 13.8% 13.2%
Rev Growth +10.1% +10.1% +20.4% +7.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 511.98M 499.47M
Total Equity 1.38B 1.30B
D/E Ratio 0.37 0.38
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 174.71M 150.78M 175.74M 223.10M
Free Cash Flow 150.62M 188.36M